Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group.

about

Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group.

Item

http://www.wikidata.org/entity/Q38749564

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Minimal Residual Disease and C ...... of Ontario MRD Working Group.

@en

type

Item

label

Minimal Residual Disease and C ...... of Ontario MRD Working Group.

@en

prefLabel

Minimal Residual Disease and C ...... of Ontario MRD Working Group.

@en

P1476

Minimal Residual Disease and C ...... of Ontario MRD Working Group.

@en

P2093

David M Malkin

http://www.w3.org/2001/XMLSchema#string

Johann Hitzler

http://www.w3.org/2001/XMLSchema#string

Nicole M Bradley

http://www.w3.org/2001/XMLSchema#string

POGO MRD Working Group

http://www.w3.org/2001/XMLSchema#string

Paul J Gibson

http://www.w3.org/2001/XMLSchema#string

Uma H Athale

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

Treating childhood acute lymphoblastic leukemia without cranial irradiation

New definition of remission in childhood acute lymphoblastic leukemia.

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.

Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.

Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

P304

973-982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25939

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26914030

http://www.w3.org/2001/XMLSchema#string